BioLargo Doubles Annual Revenues for Second Consecutive Year in 2023

BIOLARGO, INC.

2023 annual revenues more than doubled 2022, driven by Pooph pet odor control product sales.
Pooph sold through Amazon, Walmart, Chewy; BioLargo is technology partner to Pooph, Inc.
Expects first PFAS treatment technology revenues in 2024 after securing a municipal drinking water project.
Preliminary 2023 revenue estimates subject to audit; annual report expected by end of March.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.